Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 6 of 6 clinical reviews.
A critical appraisal of the SCALE Obesity and Prediabetes trial (liraglutide 3.0 mg), examining enrollment biases, generalizability gaps, statistical caveats, and post-publication commentary.
Read clinical reviewA deep dive into the SCALE Obesity trial's randomization, blinding, inclusion criteria, statistical framework, and comparator design for liraglutide 3.0 mg in chronic weight management.
Read clinical reviewDeep-dive into the SCALE Obesity trial's extension phase, weight regain after liraglutide discontinuation, durability of cardiometabolic benefits, and long-term safety signals from 3 years of follow-up data.
Read clinical reviewDeep-dive into SCALE Obesity pre-specified and post-hoc subgroup analyses for liraglutide 3.0 mg, examining differential responses by age, sex, BMI, baseline biomarkers, and race/ethnicity.
Read clinical reviewA deep-dive into the SCALE Obesity and Prediabetes RCT (2015), explaining how liraglutide 3.0 mg demonstrated meaningful weight loss versus placebo over 56 weeks and what it means for clinical practice.
Read clinical reviewA deep-dive into the SCALE Obesity trial of liraglutide 3.0 mg, examining how its results reshaped weight-management guidelines, prescribing patterns, and real-world patient selection.
Read clinical review